• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压和直立性低血压作为转甲状腺素蛋白淀粉样变性结局研究(THAOS)患者自主神经功能障碍的指标。

Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS).

机构信息

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Institute for Neurological Research Raúl Carrea, FLENI, Buenos Aires, Argentina.

出版信息

Auton Neurosci. 2019 Dec;222:102590. doi: 10.1016/j.autneu.2019.102590. Epub 2019 Oct 23.

DOI:10.1016/j.autneu.2019.102590
PMID:31726319
Abstract

INTRODUCTION

Autonomic dysfunction, an early symptom of transthyretin amyloidosis (ATTR amyloidosis), requires investigations not readily available in many clinics. Although monitoring of orthostatic hypotension (OH) will not be a substitute for more specialized tests, it can add important information about initiation of dysautonomia. The aim of this study was to investigate whether simple blood pressure (BP) monitoring may be a useful tool for evaluation of disease progression and an early sign of autonomic dysfunction.

METHODS

BP and OH data were from subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS). Characteristics associated with changes in BP and orthostatic difference were identified by regression analyses.

RESULTS

OH tended to be present relatively early in the course of disease and was more common at enrollment (11.7%) than either diarrhea (2.4%) or unintentional weight loss (3.1%). In subjects with OH at enrollment, progressive increase in systolic and diastolic orthostatic difference was observed. OH was also associated with significantly worse quality of life.

DISCUSSION

BP variability is a useful tool for assessing disease onset and severity in ATTR amyloidosis, particularly in patients with OH. Trial registration ClinicalTrials.gov: NCT00628745.

摘要

简介

自主神经功能障碍是转甲状腺素淀粉样变性(ATTR 淀粉样变性)的早期症状,需要进行许多诊所无法进行的检查。虽然直立性低血压(OH)监测不能替代更专业的测试,但它可以提供有关自主神经功能障碍起始的重要信息。本研究旨在探讨简单的血压(BP)监测是否可作为评估疾病进展和自主神经功能障碍早期迹象的有用工具。

方法

BP 和 OH 数据来自参与转甲状腺素淀粉样变性结局调查(THAOS)的受试者。通过回归分析确定与 BP 变化和直立性差异相关的特征。

结果

OH 在疾病过程中相对较早出现,且在登记时(11.7%)比腹泻(2.4%)或非故意体重减轻(3.1%)更为常见。在登记时患有 OH 的受试者中,观察到收缩压和舒张压直立性差异逐渐增加。OH 也与明显较差的生活质量相关。

讨论

BP 变异性是评估 ATTR 淀粉样变性发病和严重程度的有用工具,特别是在患有 OH 的患者中。

试验注册

ClinicalTrials.gov:NCT00628745。

相似文献

1
Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS).血压和直立性低血压作为转甲状腺素蛋白淀粉样变性结局研究(THAOS)患者自主神经功能障碍的指标。
Auton Neurosci. 2019 Dec;222:102590. doi: 10.1016/j.autneu.2019.102590. Epub 2019 Oct 23.
2
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).转甲状腺素蛋白淀粉样变性心肌病患者自主神经功能障碍特征分析(THAOS)。
Amyloid. 2022 Sep;29(3):175-183. doi: 10.1080/13506129.2022.2043270. Epub 2022 Apr 22.
3
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review.他法米替尼治疗遗传性转甲状腺素蛋白淀粉样变相关自主神经病:综述。
Clin Auton Res. 2019 Sep;29(Suppl 1):19-24. doi: 10.1007/s10286-019-00625-9. Epub 2019 Aug 12.
4
Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.非 Val30Met 遗传性转甲状腺素蛋白淀粉样变性中广泛存在的心脏和血管舒缩自主神经功能障碍。
Intern Med. 2018 Dec 1;57(23):3365-3370. doi: 10.2169/internalmedicine.1113-18. Epub 2018 Jul 6.
5
Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a systematic review.遗传性转甲状腺素蛋白淀粉样变性相关自主神经病变的特征和自然病史:系统综述。
Clin Auton Res. 2019 Sep;29(Suppl 1):1-9. doi: 10.1007/s10286-019-00630-y. Epub 2019 Aug 31.
6
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).一项针对超过 6000 名转甲状腺素蛋白淀粉样变性患者数据的长达 15 年的综合回顾:转甲状腺素蛋白淀粉样变性结局调查(THAOS)。
Orphanet J Rare Dis. 2023 Nov 10;18(1):350. doi: 10.1186/s13023-023-02962-5.
7
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).转甲状腺素蛋白心脏淀粉样变性的基因型与表型:THAOS(转甲状腺素蛋白淀粉样变性结局调查)
J Am Coll Cardiol. 2016 Jul 12;68(2):161-72. doi: 10.1016/j.jacc.2016.03.596.
8
Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).自主神经受累与遗传性转甲状腺素蛋白淀粉样变性(hATTR 淀粉样变性)。
Clin Auton Res. 2019 Apr;29(2):245-251. doi: 10.1007/s10286-018-0514-2. Epub 2018 Mar 6.
9
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.提高遗传性转甲状腺素淀粉样变性(hATTR)伴自主神经病变患者生活质量的策略。
Clin Auton Res. 2019 Sep;29(Suppl 1):25-31. doi: 10.1007/s10286-019-00624-w. Epub 2019 Sep 10.
10
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.遗传性转甲状腺素蛋白淀粉样变性的直立性低血压:流行病学、诊断和治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):33-44. doi: 10.1007/s10286-019-00623-x. Epub 2019 Aug 26.

引用本文的文献

1
Ventilatory efficiency in cardiac amyloidosis-A systematic review and meta-analysis.心脏淀粉样变性中的通气效率——一项系统评价和荟萃分析
Physiol Rep. 2025 May;13(9):e70308. doi: 10.14814/phy2.70308.
2
Wild-type transthyretin cardiac amyloidosis and aortic stenosis: Can carpal tunnel syndrome help distinguish the chicken from the egg?野生型转甲状腺素蛋白心脏淀粉样变性与主动脉狭窄:腕管综合征能否有助于分清因果?
J Intern Med. 2025 Feb;297(2):186-200. doi: 10.1111/joim.20042. Epub 2024 Nov 28.
3
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal.
遗传性转甲状腺素蛋白淀粉样变性症管理的最佳实践:来自日本、巴西和葡萄牙的真实世界经验。
Orphanet J Rare Dis. 2023 Oct 12;18(1):323. doi: 10.1186/s13023-023-02910-3.
4
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.台湾心脏病学会2023年心脏淀粉样变诊断与治疗专家共识
Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A.
5
Vagus nerve ultrasound in transthyretin familial amyloid polyneuropathy: A pilot study.转甲状腺素蛋白家族性淀粉样多发性神经病的迷走神经超声:一项初步研究。
J Neuroimaging. 2022 Mar;32(2):285-291. doi: 10.1111/jon.12956. Epub 2021 Dec 29.
6
ATTR Amyloidosis: Current and Emerging Management Strategies: State-of-the-Art Review.转甲状腺素蛋白淀粉样变性:当前及新出现的管理策略:最新综述
JACC CardioOncol. 2021 Oct 19;3(4):488-505. doi: 10.1016/j.jaccao.2021.06.006. eCollection 2021 Oct.
7
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS.来自地方性病灶的转甲状腺素蛋白淀粉样变性中Glu89Gln基因型的表型差异:THAOS的最新情况
Cardiol Ther. 2021 Dec;10(2):481-490. doi: 10.1007/s40119-021-00226-6. Epub 2021 Jun 19.
8
Epigenomic Profiles of African-American Val122Ile Carriers Reveals Putatively Dysregulated Amyloid Mechanisms.非裔美国人 Val122Ile 携带者的表观基因组谱揭示了潜在失调的淀粉样机制。
Circ Genom Precis Med. 2021 Feb;14(1):e003011. doi: 10.1161/CIRCGEN.120.003011. Epub 2021 Jan 11.
9
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.避免误诊:全科医生对转甲状腺素蛋白淀粉样变性的疑诊和诊断的专家共识建议。
BMC Fam Pract. 2020 Sep 23;21(1):198. doi: 10.1186/s12875-020-01252-4.